Patents by Inventor Amir Jazaery

Amir Jazaery has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Micro-RNA based diagnoses of ovarian and other cancers via sub-terahertz vibrational spectroscopy
    Patent number: 10287635
    Abstract: Certain exemplary embodiments can provide a method, which comprises causing a determination to be made that a body fluid sample is from a patient with cancer. The determination can be made via analyzing the body fluid sample by sub-THz resonance spectroscopy with absorption determinations being made at a plurality of frequencies between 0.05 and 1.0 THz to show a presence of specific Micro-RNAs as cancer related molecules in the body fluid.
    Type: Grant
    Filed: February 16, 2017
    Date of Patent: May 14, 2019
    Inventors: Tatiana Globus, Boris Gelmont, Amir Jazaery, Alexei Bykhovski, Igor Sizov, Aaron Moyer, Jerome Ferrance
  • Micro-RNA Based Diagnoses of Ovarian and Other Cancers Via Sub-Terahertz Vibrational Spectroscopy
    Publication number: 20170247764
    Abstract: Certain exemplary embodiments can provide a method, which comprises causing a determination to be made that a body fluid sample is from a patient with cancer. The determination can be made via analyzing the body fluid sample by sub-THz resonance spectroscopy with absorption determinations being made at a plurality of frequencies between 0.05 and 1.0 THz to show a presence of specific Micro-RNAs as cancer related molecules in the body fluid.
    Type: Application
    Filed: February 16, 2017
    Publication date: August 31, 2017
    Inventors: Tatiana Globus, Boris Gelmont, Amir Jazaery, Alexei Bykhovski, Igor Sizov, Aaron Moyer, Jerome Ferrance
  • Identification of ovarian cancer tumor markers and therapeutic targets
    Publication number: 20050095592
    Abstract: The present disclosure provides methods for classifying ovarian tumors into BRCA1-type, BRCA2-type or non-BRCA-type tumor types by measuring expression levels of a plurality of disclosed ovarian tumor markers. The markers disclosed herein are useful in the diagnosis, staging, detection, and/or treatment of ovarian cancer. Also provided are methods of selecting a treatment regimen by selecting the tumor type. Ovarian cancer-linked logarithmic expression ratios and kits for diagnosis, staging, and detection of ovarian cancer using are also provided.
    Type: Application
    Filed: February 13, 2003
    Publication date: May 5, 2005
    Inventors: Amir Jazaeri, Jeffrey Boyd, Edison Liu